mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.003 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.004 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.005 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.006 |